DOI:
10.1055/s-00043364
Pharmaceutical Fronts
LinksClose Window
References
Kovtun Y, Noordhuis P, Whiteman KR. et al.
IMGN779, a novel CD33-targeting antibody-drug conjugate with DNA-alkylating activity, exhibits potent antitumor activity in models of AML.
Mol Cancer Ther 2018;
17 (06) 1271-1279
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.